ClinicalTrials.gov
public full text
Public Domain
AMX0035 and Progressive Supranuclear Palsy
A35-009 (ORION) is a Phase 2b/3 trial to evaluate the efficacy and safety of AMX0035 in participants with Progressive Supranuclear Palsy (PSP), consisting of randomized, double blind placebo controlled phases, followed by an optional open-label extension phase.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Early Reversibility of Rocuronium After Different Doses of Neostigmine#1073938
- SUPARTZ Versus Placebo in Osteoarthritis of the Shoulder#1173875
- Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis#916155
- Best Management of Muscle Relaxation- Objective Monitoring#914222
- Validation of i-ROP DL to Detect More Than Mild ROP#1140514
Record · ID 1163209
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive